Pulse Biosciences has appointed the company's co-chairman, Paul A. LaViolette, as its new chief executive. LaViolette replaces Burke T. Barrett, who was named president and CEO of the medical ...

Pulse Biosciences (PLSE) announced the appointment of Paul LaViolette, current co-chairman of the board, as CEO. LaViolette is currently a director for Edwards Lifesciences (EW) and chairman of ...

LaViolette, current Co-Chairman of the Board, as Chief Executive Officer. "We are thrilled to have Paul assume the role of Chief Executive Officer," said Pulse Biosciences’ Co-Chairman of the ...

Pulse Biosciences today announced feasibility study data supporting its Nanosecond PFA 360° cardiac catheter system.

MIAMI - Pulse Biosciences, Inc. (NASDAQ:PLSE), a biotech company with a market capitalization of $1.08 billion and an ...

(RTTNews) - Novel bioelectric medicine company Pulse Biosciences, Inc. (PLSE) announced Friday the appointment of Paul LaViolette, current Co-Chairman of the Board, as Chief Executive Officer.

LaViolette, current Co-Chairman of the Board, as Chief Executive Officer. "We are thrilled to have Paul assume the role of Chief Executive Officer," said Pulse Biosciences’ Co-Chairman of the Board ...